Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ocean Biomedical, Inc. - Common Stock (NQ: OCEA )

0.0205 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ocean Biomedical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
US Stocks Pare Losses; Services PMI Rises In May
U.S. stocks pared some losses midway through trading, with the Dow Jones edging higher on Tuesday. The Dow traded up 0.01% to 33,287.95 while the NASDAQ fell 0.17% to 12,698.79. The S&P 500, also fell,... 
Via Benzinga
Dow Drops Over 100 Points; Lowe's Earnings Top Views
U.S. stocks traded lower this morning, with the Dow Jones dropping over 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.40% to 33,154.99 while the NASDAQ fell 0.32%... 
Via Benzinga
Why Ocean Biomedical Shares Are Surging
Ocean Biomedical Inc (NASDAQ: OCEA) shares are trading higher Tuesday after the company announced a patent award for novel cancer immu 
Via Benzinga
Ocean Biomedical Raises $25M Via Convertible Note Facility
Via Benzinga
Where Ocean Biomedical Stands With Analysts
Via Benzinga
EXCLUSIVE: Ocean Biomedical Closes Initial $10M Tranche of $27M Private Placement
Ocean Biomedical Inc (NASDAQ: OCEA) has closed the initial US $10 million tranche of a total anticipated $27 million principal amount of Senior Secured Convertible Notes in a private placement with... 
Via Benzinga
EXCLUSIVE: Ocean Biomedical Highlights New Results From Anti-Cancer Antibody Validating Tumor Suppression In Animal Models With Brain Tumor
Ocean Biomedical Inc's (NASDAQ: OCEA) co-founder, Jack Elias, published new findings in the peer-reviewed journal Cancer Research detailing the mechanisms behind the role of chitinase 3-like-1 (Chi3L1)... 
Via Benzinga
EXCLUSIVE: Ocean Biomedical's Co-Founder Outlines Detailed Data From Malaria Vaccine At Conference
Ocean Biomedical Inc's (NASDAQ: OCEA) co-founder, Jonathan Kurtis, presented details of the company's malaria vaccine and treatment approach at the PATH Malaria's annual retreat in Washington, DC. 
Via Benzinga
EXCLUSIVE: Ocean Biomedical's Co-Founder Jack Elias To Receive US Patent For Lung Fibrosis Therapeutics
Ocean Biomedical Inc's (NASDAQ: OCEA) co-founder Jack Elias, received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for his U.S. patent application covering a... 
Via Benzinga
EXCLUSIVE: Ocean Biomedical Bags $134M Backing For Innovative Research and IND Fillings
Ocean Biomedical, Inc (NASDAQ: OCEA) shared updates on crucial company activities with Benzinga on Monday.  
Via Benzinga
Why Is Ocean Biomedical (OCEA) Stock Up 50% Today?
Ocean Biomedical is popping higher on an encouraging development for its drug patent application, drawing interest toward OCEA stock. 
Via InvestorPlace
Why Shares of Ocean Biomedical Soared Thursday
The stock doubled in price over the course of the day. 
Via The Motley Fool
Tesla, Apple, Boeing, Lucid Group, Ocean Biomedical: Why These 5 Stocks Are Drawing Investors' Attention Today
Via Benzinga
Nasdaq Rises 2%; Consolidated Communications Shares Spike Higher
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 300 points on Thursday. The Dow traded up 1.09% to 34,013.93 while the NASDAQ rose 2% to 12,167. The S&P 500,... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Ocean Biomedical Stock Is Riding A Wave Higher Thursday
Ocean Biomedical Inc (NASDAQ: OCEA) shares are rising Thursday after the company announced its co-founder received a Notice of Allowance from the USPTO for his U.S. 
Via Benzinga
Ocean Biomedical (NASDAQ: OCEA) Receives U.S. Patent Approval Notice for New Malaria Treatment
Ocean Biomedical, Inc. (NASDAQ: OCEA) is engaged as a biopharmaceutical company, which is focused on the development and commercialization of 
Via Spotlight Growth
Topics Intellectual Property
Exposures Intellectual Property
Why ViewRay Shares Are Trading Lower By 32%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers CXApp Inc. (NASDAQ: CXAI) jumped 105% to $3.28 after climbing over 20% on Wednesday. 
Via Benzinga
Dow Rises Over 100 Points; Delta Air Lines Earnings Miss Views
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 100 points on Thursday. The Dow traded up 0.43% to 33,790.58 while the NASDAQ rose 1.36% to 12,091.38. The S&P... 
Via Benzinga
Nasdaq Surges 100 Points; US Producer Prices Drop In March
U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.01% to 33,650.06 while the... 
Via Benzinga
EXCLUSIVE: Ocean Biomedical's Co-Founder Expects To Receive US Patent Covering Malaria Therapeutics
Ocean Biomedical Inc's (NASDAQ: OCEA) co-founder, Jonathan Kurtis, has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for his U.S. 
Via Benzinga
7 Cheap Stocks That Are Worth Your Attention
Finding cheap stocks that are worth an investment can be tricky, but the Portfolio Grader is a tool you can use to narrow the field. 
Via InvestorPlace
GitLab, United Airlines And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. GitLab Inc. (NASDAQ: GTLB) shares dipped 31.1% to $30.75 in pre-market... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 13, 2023
Via Benzinga
Why JAKKS Pacific Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Barnes & Noble Education, Inc. (NYSE: BNED) jumped 39% to $2.39 after the company posted better-than-expected quarterly sales. 
Via Benzinga
Why Barnes & Noble Education Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket
Gainers Barnes & Noble Education, Inc. (NYSE: BNED) rose 25% to $2.15 in pre-market trading after the company posted better-than-expected quarterly sales. 
Via Benzinga
Gap, Oracle And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Tesla, SVB, Ocean Biomedical, Docusign, Oracle: Why These 5 Stocks Are Drawing Investors' Attention Today
Via Benzinga
US Stocks Turn Lower; S&P 500 Down 1%
U.S. stocks turned lower toward the end of trading, with the Dow Jones dropping around 300 points on Thursday. The Dow traded down 0.88% to 32,510.83 while the NASDAQ fell 1.34% to 11,421.06. The S&P... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.